Confirmed pathology
Biopsy or surgical pathology should clearly confirm NSCLC and, when possible, the histologic subtype and immunohistochemistry profile.
Oncology evaluation directory
Thoracic oncology
Non-small Cell Lung Cancer Evaluation
A physician-led file review for documented NSCLC, organized around histology, stage, molecular profile, prior therapy, current symptoms and the practical question of whether a Cuba-related oncology discussion is appropriate.
Medical disclaimer: This page is informational and coordination-focused. It does not diagnose, prescribe, promise treatment suitability or replace urgent local medical care.
Clinical file logic
What the specialist needs to understand before any treatment discussion.
Non-small cell lung cancer is not reviewed as a single generic diagnosis. The medical file must show whether the tumor is adenocarcinoma, squamous cell carcinoma or another NSCLC subtype, because this can affect biomarker testing, treatment history, safety questions and specialist interpretation.
For international coordination, the most important work is not to promise a treatment. It is to organize the file so the reviewing physician can understand what has been confirmed, what is still uncertain, what has already been tried and what the patient is asking to evaluate.
Current stage and disease distribution
Recent CT, PET-CT, brain imaging when clinically relevant and reports describing lymph nodes, pleura, liver, bone, adrenal or brain involvement are organized.
Molecular and immune profile
EGFR, ALK, ROS1, BRAF, MET exon 14, RET, NTRK, KRAS, HER2 and PD-L1 are reviewed when available; missing tests are clearly marked rather than assumed.
Prior treatment response
Surgery, radiotherapy, platinum chemotherapy, immunotherapy, targeted therapy, maintenance therapy and dates of progression are summarized in sequence.
Performance and risk status
Shortness of breath, oxygen use, pleural effusion, pain, weight loss, infection, organ function and treatment tolerance are reviewed before travel or treatment planning discussions.
The specialist question
The file should ask a precise question: second opinion, suitability discussion, supportive care route, post-progression options or Cuba-based evaluation.
Evaluation matrix
How the case is reviewed without reducing it to a diagnosis name.
Each item below affects how the file is interpreted, what the physician can answer and whether additional documents are needed before a responsible response.
Pathology integrity
Report date, tissue source, immunohistochemistry and whether the diagnosis is primary lung cancer or metastasis from another tumor are checked.
Biomarker completeness
Molecular and PD-L1 results help frame the discussion and avoid ignoring standard targeted or immunotherapy considerations.
Disease tempo
Slow progression, rapid symptomatic decline, oligometastatic disease and widespread progression are not reviewed the same way.
Cuba discussion boundary
CIMAvax-EGF or Vaxira are presented only as physician-review topics for selected contexts, never as universal or guaranteed cancer treatment.
Documents to prepare
A complete medical file prevents delay and unrealistic expectations.
Most delays happen when the diagnosis is described verbally but the file lacks dates, reports, imaging, pathology or the current specialist recommendation. The documents below are requested before the file is considered ready for review.
Cuba context
How Cuba-related options are framed responsibly.
The page does not present a hospital visit or travel plan as automatically suitable. Any Cuba-related discussion remains conditional on physician review of the current file.
Standard oncology remains the baseline
Surgery, systemic therapy, radiation, targeted therapy, immunotherapy and supportive care remain physician-led according to stage, biomarker status and prior response.
Cuban biotechnology is reviewed carefully
CIMAvax-EGF and Vaxira may be discussed only after the file is reviewed and only when the clinical context is relevant.
Travel is not the first decision
The first decision is whether the file is complete enough for a responsible specialist opinion. Travel or treatment logistics come later.
When local care comes first
Do not wait for international review if urgent symptoms are present.
International coordination should never delay emergency care. If any of the following are present, the patient should be assessed locally first.
- Severe shortness of breath, oxygen instability or chest pain.
- Coughing blood, suspected pulmonary embolism, fever with low white blood cells or uncontrolled infection.
- New neurological symptoms, uncontrolled pain, spinal cord compression concern or rapidly worsening performance.
Coordination pathway
From records to written next steps.
- File intakeReports, imaging, summaries and current symptoms are uploaded through the application flow.
- Quality checkThe coordination team checks readability, dates, translation needs and missing items.
- Specialist routingThe case is prepared around a clear medical question and routed to the relevant review pathway.
- Written responseThe patient receives an organized next-step explanation before travel, payment or treatment logistics are considered.
Questions
Before starting the application.
Does this page mean I am suitable for a Cuba-based treatment?
No. It explains how the file is organized for review. Suitability, route, timing and safety can only be determined by physicians after reviewing the complete current record.
Can I send only a short summary?
A summary helps, but it is not enough for most oncology reviews. Pathology, imaging, treatment history, lab results and the latest oncology note are usually needed.
Will the coordinator choose my treatment?
No. Cuba Health Assist coordinates records, communication, translation support and logistics. Medical decisions remain with licensed physicians and the patient’s treating team.
What happens if my file is incomplete?
The team will request missing reports before presenting the case as ready. This protects the patient from receiving a weak or unrealistic response.
Can urgent symptoms be handled through this page?
No. Severe or rapidly worsening symptoms require local emergency or oncology care first. International coordination is not an emergency service.
Related evaluation pages
Other oncology files reviewed in the same clinical directory.
Start with the file
Submit documents before making a travel or treatment decision.
A coordinator will organize the medical information and guide the next step according to specialist review. The process is designed to be transparent, clinically cautious and written.